Honoring Dr. Seyed Amirhossein Tavakoli at the 13th Technology Veterans Appreciation Ceremony of Pardis Technology Park

Table of contents
13th Ceremony Honoring Pioneers and Top Innovators at Pardis Technology Park
The 13th annual ceremony recognizing pioneers and leading innovators at Pardis Technology Park was held on February 4, 2025. During this prestigious event, Dr. Seyed Amirhossein Tavakoli, CEO of Iranian Tissue Product Company (Regen Allograft), was honored as one of the distinguished pioneers in technology. This achievement is a great honor for Iranian Tissue Product Company and the scientific and technological community of the country.
Dr. Seyed Amirhossein Tavakoli: Recognized Pioneer at Pardis Technology Park
With years of valuable experience in advanced medical and technological fields, Dr. Tavakoli has played a crucial role in the advancement of life sciences, particularly in the development of allograft products derived from human tissue. In addition to his leadership at Iranian Tissue Product Company (Regen Allograft), he is a faculty member at the Research Center for Transplantation Products Bank at Tehran University of Medical Sciences (TUMS) and a member of the American Association of Tissue Banks (AATB) and the International Federation of Inventors’ Associations.
As the co-founder and CEO of Iranian Tissue Product Company (Regen Allograft), Dr. Tavakoli has focused on the production of innovative biological products, transforming the company into a pioneer in the biotechnology and medical technology sectors. This knowledge-based company leverages cutting-edge expertise and top researchers to manufacture high-quality products that enhance medical treatments. Some of its key Allograft products include aortic and pulmonary heart valve allografts, freeze-dried (lyophilized) bone allografts, fascia lata membrane allografts, lyophilized and sterile amniotic membrane allografts, tendon allografts, mineralized and demineralized bone powder (MBA & DBM), and human collagen membrane, all of which are used in orthopedic, cardiovascular, dental, and reconstructive surgeries.
Honoring Innovators at Pardis Technology Park
According to the Public Relations Office of the International Innovation Zone of Iran, the event was attended by Mehdi Saffari-Nia, President of Pardis Technology Park, Ruhollah Dehghani Firouzabadi, former Vice President for Science and Technology, and executives from member companies of the International Innovation Zone of Iran. During the ceremony, three distinguished pioneers in technology were recognized, including Dr. Seyed Amirhossein Tavakoli, Dr. Rasoul Dinarvand, and Dr. Mohammad Hossein Hoshdar.
In addition to honoring technology pioneers, three top innovators in research and development at Pardis Technology Park in 2025 were also recognized. These innovators included Dr. Ahmad Firouzpour from Zist Takhmir Company, Dr. Aida Mousavi from Rezitan Company, and Engineer Roya Soleimanian from Pouyesh Darou Company, all of whom have made significant contributions to the advancement of cutting-edge technologies.
Iranian Tissue Product Company: A Leader in Medical Innovations
As a knowledge-based company active in the fields of medical and biological technologies, Iranian Tissue Product Company has consistently pursued the development of science and technology. By utilizing the latest scientific knowledge and expertise of top specialists, it has become a leading company in the field of tissue banks and stem cell technologies.
The company has played a key role in enhancing the quality of medical services with its advanced products such as heart valve allografts and amniotic membrane allografts. Additionally, other products like freeze-dried bone shaft allografts, tendon allografts, demineralized bone powder (DBM), and collagen membranes have significantly improved the scientific and technological aspects of orthopedic treatments and reconstructive surgeries.
During an interview on the sidelines of the ceremony, Dr. Tavakoli emphasized the importance of advancing biological technologies and improving national healthcare standards, stating: “At Iranian Tissue Product Company, we continuously strive to utilize cutting-edge knowledge and produce high-quality products to enhance medical treatments and improve patients’ quality of life.”
Final Remarks
Being recognized as a distinguished technology pioneer by Dr. Seyed Amirhossein Tavakoli is a great honor for Iranian Tissue Product Company and all its employees. The company remains committed to advancing innovative technologies and providing top-tier medical solutions.
📌 For more information about Iranian Tissue Product Company and its activities, click here.
Relevant Posts

Free consultation
Do you need counseling?
The professional and specialized team at Allograft is ready to assist you